AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
GSK's RSV Vaccine Receives Expanded Approval in Europe
August 30, 2024 12:15 AM AEST| By Team Kalkine MediaOn Thursday, GSK,(LSE:GSK),announced that the European Commission has approved its respiratory syncytial virus (RSV) vaccine, Arexvy, for use in adults aged 50 to 59 who are at increased risk of severe RSV-related illness. This approval marks the fir...
Totally Secures Multiple New Contracts and Extensions
August 29, 2024 11:37 PM AEST| By Team Kalkine MediaOn Thursday, Totally,(LSE:TLY),, a healthcare services company, announced several new contracts and extensions in England and Ireland, with a total value estimated at approximately £4 million. These agreements mark a significant expansion of Totally’...
Ananda Developments Publishes Whitepaper on CBD Clinical Research Gap
August 29, 2024 10:13 PM AEST| By Team Kalkine MediaAnanda Developments Plc has released a whitepaper detailing the potential therapeutic benefits and scope of cannabidiol (CBD). The document aims to address the significant gap in robust clinical data needed to fully assess CBD's efficacy and safety a...
Totally Shares Surge 10% After £1M New Business Win
August 29, 2024 10:02 PM AEST| By Team Kalkine MediaShares of Totally PLC,(LSE:TLY),surged 10% following the announcement of several new contracts and extensions for its urgent and elective care services across England and Ireland.,The health and wellbeing group secured a notable insourcing contract t...
GSK Optimistic on Zantac Lawsuit and Japan Approvals
August 28, 2024 08:45 PM AEST| By Team Kalkine MediaOn Wednesday, GSK,(LSE:GEK),announced several significant updates. The company welcomed a decision from the Delaware Supreme Court to review a lower court ruling that permitted the introduction of expert evidence in ongoing litigation related to its...
Polarean Appoints Xenon MRI Expert as Chief Medical Advisor
August 28, 2024 02:52 PM AEST| By Team Kalkine MediaPolarean Imaging,(LSE:POLX),has announced the appointment of Dr. Chase Hall as its chief medical advisor. Dr. Hall, renowned for his expertise in pulmonary, critical care, and sleep medicine, is set to enhance the company's capabilities in respirator...
-Copy_08_27_2024_15_08_59_207354.jpg)
Diaceutics Reports Advancements in Rare-Disease Offerings
August 28, 2024 01:08 AM AEST| By Team Kalkine MediaDiaceutics,(LSE:DXRX),announced a major enhancement to its rare-disease offerings on Tuesday, marked by the acquisition of a new contract designed to support the commercialization of a therapy for rare diseases.,The AIM-listed company revealed that t...
Belluscura Shares Surge on Strong Sales and Improved Outlook
August 28, 2024 01:07 AM AEST| By Team Kalkine MediaBelluscura,(LSE:BELL),, known for its development of lightweight and portable oxygen enrichment technology, reported significant sales growth and an optimistic trading outlook on Tuesday as it geared up for the full commercial launch of its new DISCO...
Faron Pharmaceuticals Gains US Fast-Track Approval for Bexmarilimab
August 28, 2024 12:04 AM AEST| By Team Kalkine MediaFaron Pharmaceuticals Limited,(LSE:FARN),has received fast-track approval from the US Food and Drug Administration (FDA) for its leading drug candidate, bexmarilimab, intended to treat relapsed or refractory myelodysplastic syndrome (r/r MDS) in comb...
Shield Therapeutics Shares Rise 7% After Canada Approval
August 27, 2024 09:00 AM AEST| By Team Kalkine MediaShares in Shield Therapeutics PLC,(LSE:STX),saw a 7% rise in early trading following the approval of its drug, Accrufer (ferric maltol), by Health Canada for the treatment of iron deficiency anaemia (IDA) in adults. This significant regulatory approv...
AstraZeneca May Shift UK Vaccine Production to the US
August 24, 2024 12:28 AM AEST| By Team Kalkine MediaAstraZeneca,(LSE:AZN),has indicated that it might relocate its vaccine manufacturing operations from the UK to the United States if ongoing discussions with the new Labour government over state aid cuts remain unresolved, according to a report by the...
GSK (LSE:GSK) Receives US FDA Breakthrough Therapy Designation for B7-H3-Targeted ADC in Relapsed Extensive-Stage Small-Cell Lung Cancer
August 20, 2024 05:48 PM AEST| By Team Kalkine MediaGSK plc (LSE/NYSE:GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to GSK5764227 (GSK'227), the Company’s investigational B7-H3-targeted antibody-drug conjugate (ADC). This designation i...
-Copy_08_16_2024_18_09_35_877328.jpg)
AstraZeneca's Imfinzi Receives New US Approval for Early-Stage Lung Cancer
August 16, 2024 09:00 AM AEST| By Team Kalkine MediaAn prominent player of,Healthcare sector,,AstraZeneca PLC has announced that its immunotherapy drug Imfinzi (durvalumab) has been granted an additional approval by the US Food and Drug Administration (FDA). The new approval allows Imfinzi to be used...
IXICO Expects Positive Performance in FY24 with New Contract Wins Boosting Revenue Outlook
August 14, 2024 06:31 PM AEST| By Team Kalkine MediaIXICO plc (LSE:IXI), a leading medical imaging and advanced analytics company focused on neuroscience, has issued a promising trading update for the fiscal year ending 30 September 2024 (FY24). The company, renowned for delivering cutting-edge insigh...
AstraZeneca Becomes First UK-Listed Firm to Hit £200 Billion
August 14, 2024 09:00 AM AEST| By Team Kalkine MediaAstraZeneca PLC (,LSE:AZN,) has made history as the first company listed on the London Stock Exchange to reach a market valuation exceeding £200 billion. This milestone was achieved following a 1.2% increase in the company's share price on Tuesday, w...
IQ-AI Moves Closer to FDA Review with Phase 1 Trial Wrap-Up
August 14, 2024 09:00 AM AEST| By Team Kalkine MediaIQ-AI Ltd has announced that its Phase 1 clinical trial for IB003, a gallium maltolate treatment for children's brain cancer, is nearing completion. This marks a significant milestone for the,healthcare Sector,company, which focuses on advanced medic...
Celadon Pharmaceuticals Shares Fall as Funding Delays Impact Financial Position
August 12, 2024 08:33 PM AEST| By Team Kalkine MediaCeladon Pharmaceuticals PLC (LSE: CEL) announced on Monday that it is still awaiting essential cash inflows, though its operations remain aligned with internal expectations.,Market Reaction and Share Performance,The company's shares dropped by 47% to...
Bivictrix Therapeutics Plans AIM Delisting to Advance Pipeline as Private Entity
August 12, 2024 08:31 PM AEST| By Team Kalkine MediaBivictrix Therapeutics PLC (LSE: BVX) announced on Monday its decision to delist from AIM in order to seek funding as a private company to advance its drug development pipeline.,Financial Performance and Delisting Rationale,The company, based in Ches...
New Research Partnership Aims to Advance Corneal Treatment
August 12, 2024 08:22 PM AEST| By Team Kalkine MediaBSF Enterprise PLC (LSE: BSFA), a biotech company listed on the Main Market and owner of Kerato Ltd, has announced a research partnership with the University of Montreal in Canada. This agreement outlines the terms for a collaborative effort aimed at...
Genedrive Secures Initial Order for CYP2C19-ID Test Following NICE Endorsement
August 12, 2024 08:13 PM AEST| By Team Kalkine MediaGenedrive plc (LSE:GDR), a leader in point-of-care pharmacogenetic testing, has announced the receipt of an initial order for its CYP2C19-ID Kit and associated instruments, valued at approximately £0.1 million. This order follows the recent endorseme...
AI on the Rise: A Look at Top AI Companies and Their Stocks